Regional Summit Series on Genitourinary Malignancies – New York, NY
July 20, 2019
Oncology Meeting Innovations’ (OMI’s) Regional Summit on Genitourinary Malignancies is a one-day meeting that engages local community oncologists to discuss the current treatment options in bladder cancer, renal cell carcinoma, and prostate cancer. Topics will include recently approved drugs and agents in late-stage development, best practices for employing approved compounds in GU cancers, and relevant case presentations. This meeting will assemble a distinguished group of key opinion leaders to present leading strategies for employing the latest advances, managing risk, and prolonging patient survival. Additionally, the audience will have the opportunity to engage the experts with questions and case-study discussion.
- Discuss the treatment landscape for genitourinary malignancies.
- Examine the evolving role of genomics in the treatment of renal cell carcinoma, bladder cancer, and prostate cancer.
- Analyze therapies in late-stage development and how they will be utilized as treatment options.
- Engage with leading experts to deliberate newest practices and novel therapies.
Robert Motzer, MD
Jack and Dororthy Byrne Chair in Clinical Oncology
Memorial Sloan Kettering Cancer Center
New York, NY
Park Central Hotel New York
The Park Central Hotel New York is at 870 7th Avenue in New York, NY, squarely amidst the bustling center of Midtown Manhattan. The plenary session will be held in the Manhattan Ballroom, Mezzanine level with access only from the lobby of the hotel. Contact www.parkcentralny.com for more information regarding the venue.